| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | NEUTRAL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.40▼ | 1.39▲ | 1.39▲ | 1.40 | 1.42▼ |
| MA10 | 1.39▲ | 1.39▲ | 1.40▼ | 1.39▲ | 1.47▼ |
| MA20 | 1.39▲ | 1.40▼ | 1.39▲ | 1.40▼ | 1.36▲ |
| MA50 | 1.39▲ | 1.40▼ | 1.39▲ | 1.43▼ | 1.45▼ |
| MA100 | 1.40▼ | 1.38▲ | 1.40▼ | 1.34▲ | 1.42▼ |
| MA200 | 1.38▲ | 1.45▼ | 1.46▼ | 1.36▲ | 1.79▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.001▼ | -0.001▼ | 0.002▲ | 0.008▲ |
| RSI | 51.518▲ | 50.252▲ | 50.465▲ | 48.409▼ | 49.549▼ |
| STOCH | 83.333▲ | 38.796 | 28.333 | 74.919 | 39.679 |
| WILL %R | -16.667▲ | -50.000 | -50.000 | -20.968▲ | -53.548 |
| CCI | 70.647 | -3.784 | -10.853 | 25.267 | -11.576 |
| CDL | $NNVC Doji Candlestick Pattern Detected | Set Alert |
|
Tuesday, July 08, 2025 01:00 PM
SHELTON, CT / ACCESS Newswire / July 1, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC ) (the "Company"), and a clinical stage, leading global pioneer in the development of ...
|
|
Tuesday, July 08, 2025 01:00 PM
Get the latest NanoViricides, Inc. (NNVC) stock news and headlines to help you in your trading and investing decisions.
|
|
Monday, July 07, 2025 02:28 AM
NanoViricides highlighted several key reasons for prioritizing MPox as the first indication for NV-387's Phase II development, even with strong efficacy data in animal studies for other major viral ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/07/25 | 1.39 | 1.40 | 1.37 | 1.395 | 118,184 |
| 10/07/25 | 1.40 | 1.42 | 1.3601 | 1.41 | 107,220 |
| 09/07/25 | 1.35 | 1.42 | 1.34 | 1.40 | 172,900 |
| 08/07/25 | 1.38 | 1.42 | 1.37 | 1.39 | 132,300 |
| 07/07/25 | 1.37 | 1.42 | 1.37 | 1.38 | 174,919 |
| 03/07/25 | 1.35 | 1.4382 | 1.35 | 1.38 | 141,523 |
| 02/07/25 | 1.35 | 1.41 | 1.34 | 1.39 | 137,416 |
| 01/07/25 | 1.41 | 1.44 | 1.38 | 1.40 | 330,900 |
| 30/06/25 | 1.37 | 1.40 | 1.32 | 1.40 | 171,700 |
| 27/06/25 | 1.36 | 1.42 | 1.33 | 1.40 | 628,000 |
|
|
||||
|
|
||||
|
|